ascendis transcon glp-1 program YUVIWEL (navepegritide), approved by the US FDA on February 27, 2026, is indicated to increase linear growth in pediatric patients (≥ 2 years) with achondroplasia with open epiphyses. References: https://www.fda.gov/drugs/novel-drug-approvals-fda Weight-Loss Drug Zepbound Is Synbiotic Size:2 oz (30 Day Supply)

ascendis transcon glp-1 program YUVIWEL (navepegritide), approved by the US FDA on February 27, 2026, is indicated to increase linear growth in pediatric patients (≥ 2 years) with achondroplasia with open epiphyses. References: https://www.fda.gov/drugs/novel-drug-approvals-fda Weight-Loss Drug Zepbound Is Synbiotic Size:2 oz (30 Day Supply)

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid | WIRED

These agents include: Liraglutide (Victoza, Saxenda) – once-daily injection Semaglutide (Ozempic, Wegovy) – once-weekly Tirzepatide (Mounjaro) – a dual GLP-1/GIP agonist From Glycaemic Control to Weight Regulation GLP-1RAs were initially licensed to lower HbA1c in people with Type 2 diabetes, offering an alternative to sulfonylureas and insulin

Synbiotic

Size:2 oz (30 Day Supply)

Beyond Rybelsus, other companies are exploring oral GLP-1 pills